Source:http://linkedlifedata.com/resource/pubmed/id/16123077
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2005-8-26
|
pubmed:abstractText |
The role of progesterone withdrawal in human parturition continues to provoke controversy. One possible mechanism by which functional progesterone withdrawal may be achieved is by a decrease in the circulating concentration of its bioactive metabolites. The progesterone metabolite 5beta-dihydroprogesterone (5betaDHP) has been shown to be a potent tocolytic in vitro. We quantified plasma concentrations of 5betaDHP in association with the onset of spontaneous labour in women at term and steroid 5beta-reductase mRNA expression in placenta, myometrium, chorion and amnion in relation to parturition, using real time RT-PCR. Serial blood samples were obtained from patients late in pregnancy, before term labour, during term labour and within the first 24 h postpartum. Following organic solvent extraction, steroids including 5betaDHP were separated by high-performance liquid chromatography (HPLC) and then quantified by radioimmunoassay (RIA). 5betaDHP concentration decreased two-fold (P = 0.00001, n = 25) from 0.317 +/- 0.039 nmol/ml to 0.178 +/- 0.017 nmol/ml in association with active labour. Tissue 5beta-reductase mRNA-relative abundance was determined in placenta, myometrium, chorion and amnion obtained from labouring and non-labouring women. In placenta and myometrium, relative expression decreased significantly in association with labour, by about two-fold and 10-fold, respectively. These data are consistent with a possible role for 5betaDHP in the onset of spontaneous human labour. Further studies exploring this hitherto unrecognized endocrinological pathway are indicated.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1360-9947
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
495-501
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16123077-5-alpha-Dihydroprogesterone,
pubmed-meshheading:16123077-Amnion,
pubmed-meshheading:16123077-Chorion,
pubmed-meshheading:16123077-Female,
pubmed-meshheading:16123077-Humans,
pubmed-meshheading:16123077-Labor, Obstetric,
pubmed-meshheading:16123077-Myometrium,
pubmed-meshheading:16123077-Oxidoreductases,
pubmed-meshheading:16123077-Parturition,
pubmed-meshheading:16123077-Placenta,
pubmed-meshheading:16123077-Pregnancy,
pubmed-meshheading:16123077-RNA, Messenger
|
pubmed:year |
2005
|
pubmed:articleTitle |
5 Beta-dihydroprogesterone and steroid 5 beta-reductase decrease in association with human parturition at term.
|
pubmed:affiliation |
Pregnancy Research Centre and University of Melbourne Department of Obstetrics and Gynaecology, Royal Women's Hospital, Carlton, Victoria, Australia. penny.sheehan@rwh.org.au
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|